BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25190021)

  • 21. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
    Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
    Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
    Park SJ; Miyake H; Hara I; Eto H
    Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.
    Mettlin C; Lee F; Drago J; Murphy GP
    Cancer; 1991 Jun; 67(12):2949-58. PubMed ID: 1710531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
    Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
    Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.
    Ramos CG; Valdevenito R; Vergara I; Anabalon P; Sanchez C; Fulla J
    Urol Oncol; 2013 Nov; 31(8):1522-6. PubMed ID: 22687565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer.
    Di Franco CA; Jallous H; Porru D; Giliberto GL; Cebrelli T; Tinelli C; Rovereto B
    Arch Ital Urol Androl; 2017 Mar; 89(1):55-59. PubMed ID: 28403597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].
    Voisin E; Piaton E; Rivain T; Duco F
    Prog Urol; 1992 Dec; 2(6):973-9. PubMed ID: 1284556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.
    Baco E; Rud E; Eri LM; Moen G; Vlatkovic L; Svindland A; Eggesbø HB; Ukimura O
    Eur Urol; 2016 Jan; 69(1):149-56. PubMed ID: 25862143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of digital rectal examination, serum prostate-specific antigen, transrectal ultrasonography and systematic prostate biopsy for the detection of organ-confined prostate cancer.
    Gohji K; Okamoto M; Morisue K; Fujii A
    Int J Urol; 1995 May; 2(2):116-20. PubMed ID: 7553283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
    Roehrborn CG; Pickens GJ; Sanders JS
    Urology; 1996 Mar; 47(3):347-52. PubMed ID: 8633400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen, digital rectal examination, and transrectal ultrasound in predicting the probability of cancer.
    Drago JR; York JP
    J Surg Oncol; 1992 Mar; 49(3):172-5. PubMed ID: 1372376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer.
    McDonald AC; Vira M; Shen J; Sanda M; Raman JD; Liao J; Patil D; Taioli E
    Prostate; 2018 May; 78(6):411-418. PubMed ID: 29383739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.